Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Therapeutics Inc (OTCQB:BTHE)

0.20
Delayed Data
As of Jul 29
 0.00 / 0.00%
Today’s Change
0.08
Today|||52-Week Range
0.80
-69.17%
Year-to-Date
No recent news for Boston Therapeutics Inc.

Today’s Trading

Previous close0.20
Today’s open0.18
Day’s range0.17 - 0.20
Volume112,600
Average volume (3 months)30,826
Market cap$7.7M
Dividend yield--
Data as of 3:36pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)+33.33%
Earnings growth (this year)-20.83%
Earnings growth (next 5 years)--
Revenue growth (last year)-38.29%
P/E ratioNM
Price/Sales124.16
Price/Book103.09

Competitors

No competitors data available.

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$199.6K
Annual profit (last year)-$4.7M
Net profit margin-2,354.89%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, Chief Executive Officer &
Treasurer
David Platt
Director-
Business Operations
Louise Gelinas
Corporate headquarters
Manchester, New Hampshire

Forecasts